ISDS Case Map
intellectual property
The adoption of the measures proposed by the EU could put the sustainability of access to health policies in Brazil at risk, as they could sharply increase public expenditures on medicines.
As leaked by Greenpeace
The latest plan to get the controversial trade deal up and running involves freezing some of its controversial rules, including rules for biologic drugs, an expensive class of medicines often used to treat conditions such as cancer and rheumatoid arthritis.
As the TPP-11 meet to attempt to revive the TPP without the US, the research findings show how damaging the original medicine proposals would be.
India firm in opposing proposals that could hinder global access to affordable generic drugs
Healthcare watchers are calling on India to resist RCEP
Access to health products is non-negotiable; the Indian Government should reject the bullying tactics of the US based medical device industry.
This article is part of a series about what the renegotiation of the North American Free Trade Agreement means for the knowledge economy in Canada and for the people who turn ideas into innovations within one of the world’s largest free trade zones.
The US must push a range of economic issues with India, including intellectual property, standard and non-tariff barriers, President Donald Trump’s nominee to be the next envoy to India has told lawmakers.
Switzerland insists on intellectual property commitments beyond TRIPS.
